SPOTLIGHT: Qiagen inks eGene acquisition deal

Netherlands-based Qiagen has struck a deal to buy Irvine, CA-based eGene for $34 million, adding a genetic analysis system that it says will improve lab productivity. EGene has developed and is commercializing a patented sample separation and analysis technology based on capillary electrophoresis. Release

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.